openPR Logo
Press release

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market to Exceed USD 34.22 Billion by 2031 - Transparency Market Research Inc.

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market

The global ๐ˆ๐๐ƒ (๐”๐ฅ๐œ๐ž๐ซ๐š๐ญ๐ข๐ฏ๐ž ๐‚๐จ๐ฅ๐ข๐ญ๐ข๐ฌ ๐š๐ง๐ ๐‚๐ซ๐จ๐ก๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž) ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ is estimated to attain a valuation of US$ 34.22 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.8% during the forecast period, 2022-2031.

The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the IBD (Ulcerative Colitis and Crohn's Disease) Treatment industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in simple manner. In addition, the report delivers data on the volume, share, revenue, production, and sales in the market.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ (๐”๐ฌ๐ž ๐‚๐จ๐ซ๐ฉ๐จ๐ซ๐š๐ญ๐ž ๐Œ๐š๐ข๐ฅ ๐ˆ๐ ๐Ÿ๐จ๐ซ ๐๐ฎ๐ข๐œ๐ค ๐‘๐ž๐ฌ๐ฉ๐จ๐ง๐ฌ๐ž) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1473

The report by TMR is the end-product of a study performed using different methodologies including the PESTEL, PORTER, and SWOT analysis. The study with the help of these models shed light on the key financial considerations that players in the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market need to focus on identifying competition and formulate their marketing strategies for both consumer and industrial markets. The report leverages a wide spectrum of research methods including surveys, interviews, and social media listening to analyze consumer behaviors in its entirety.

๐ˆ๐๐ƒ (๐”๐ฅ๐œ๐ž๐ซ๐š๐ญ๐ข๐ฏ๐ž ๐‚๐จ๐ฅ๐ข๐ญ๐ข๐ฌ ๐š๐ง๐ ๐‚๐ซ๐จ๐ก๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž) ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐•๐š๐ฅ๐ฎ๐ž ๐‚๐ก๐š๐ข๐ง

The study on the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market presents a granular assessment of the macroeconomic and microeconomic factors that have shaped the industry dynamics. An in-depth focus on industry value chain help companies find out effective and pertinent trends that define customer value creation in the market. The analysis presents a data-driven and industry-validated frameworks for understanding the role of government regulations and financial and monetary policies. The analysts offer a deep-dive into the how these factors will shape the value delivery network for companies and firms operating in the market.

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ | ๐ˆ๐ฆ๐ฆ๐ž๐๐ข๐š๐ญ๐ž ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐š๐ญ - https://www.transparencymarketresearch.com/checkout.php?rep_id=1473<ype=S

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Branding Strategies and Competitive Strategies

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ค๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ฌ๐œ๐ซ๐ฎ๐ญ๐ข๐ง๐ข๐ณ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ ๐š๐ซ๐ž:

What are some of the recent brand building activities of key players undertaken to create customer value in the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market?
Which companies are expanding litany of products with the aim to diversify product portfolio?
Which companies have drifted away from their core competencies and how have those impacted the strategic landscape of the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market?
Which companies have expanded their horizons by engaging in long-term societal considerations?
Which firms have bucked the pandemic trend and what frameworks they adopted to stay resilient?
What are the marketing programs for some of the recent product launches?
๐“๐ก๐ž ๐ฅ๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐ค๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐ฉ๐ž๐ซ๐š๐ญ๐ข๐ง๐  ๐ข๐ง ๐ญ๐ก๐ž ๐ˆ๐๐ƒ (๐”๐ฅ๐œ๐ž๐ซ๐š๐ญ๐ข๐ฏ๐ž ๐‚๐จ๐ฅ๐ข๐ญ๐ข๐ฌ ๐š๐ง๐ ๐‚๐ซ๐จ๐ก๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž) ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ง๐š๐ฆ๐ž๐ฌ:

Pfizer, Inc., Janssen Biotech, Inc. (Johnson & Johnson), Health Companies, Inc., Allergan plc., Takeda Pharmaceutical Company Limited, AbbVie, Inc., Novartis AG, and UCB, Inc.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1473

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Assessment of Avenues and Revenue Potential in Key Geographies

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ค๐ž๐ฒ ๐š๐ฌ๐ฉ๐ž๐œ๐ญ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ณ๐ž๐ฌ ๐š๐ง๐ ๐ฌ๐ก๐ž๐๐ฌ ๐ฅ๐ข๐ ๐ก๐ญ ๐š๐ซ๐ž:

Which regions are witnessing rise in investments in the supply chain networks?
Which countries seems to have benefitted from recent import and export policies?
Which regions have witnessed decline in consumer demand due to economic and political upheavals?
Which are some the key geographies that are likely to emerge as lucrative markets?
Which regions are expected to lose shares due to pricing pressures?
Which regions leading players are expected to expand their footprints in the near future?
What are some the sustainability trends impacting the logistics and supply chain dynamics in the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market?
What are some of the demographic and economic environments that create new demand in developing economies?
How are changing government regulations shaping business strategies and practices?
๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก -

๐๐ฅ๐š๐๐๐ž๐ซ ๐’๐œ๐š๐ง๐ง๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ - https://www.globenewswire.com/en/news-release/2023/08/14/2724505/32656/en/Global-Bladder-Scanners-Market-Poised-for-Growth-Projected-CAGR-of-5-5-from-2022-2031-Reaching-Over-225-Million-TMR-Report.html

๐๐š๐ฌ๐จ๐ฉ๐ก๐š๐ซ๐ฒ๐ง๐ ๐ž๐š๐ฅ ๐’๐ฐ๐š๐›๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ - https://www.globenewswire.com/en/news-release/2023/08/14/2724507/32656/en/Global-Nasopharyngeal-Swabs-Market-Valued-at-267-3-Million-in-2022-Projected-CAGR-of-2-4-from-2023-2031-TMR-Report.html

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market to Exceed USD 34.22 Billion by 2031 - Transparency Market Research Inc. here

News-ID: 3223022 • Views: โ€ฆ

More Releases from Transparency Market Research

Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 Billion by 2035 | Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 โ€ฆ
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics asโ€ฆ
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising Demand for Bio-Based Chemicals and Expanding Foundry Industry | TMR
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D โ€ฆ
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035. This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific. Gain aโ€ฆ
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by 2035 at a CAGR of 3.5% Driven by Infrastructure Expansion and Climate-Resilient Concrete Demand
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by โ€ฆ
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability. Despite being a mature segment withinโ€ฆ
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn by 2035 at a CAGR of 4.2%
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn โ€ฆ
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintainโ€ฆ

All 5 Releases


More Releases for IBD

Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An โ€ฆ
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies. Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg Imaging techniques play a crucialโ€ฆ
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period. Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149 Key Market Highlights โ€ข Crohn's Disease Dominates: Crohn's diseaseโ€ฆ
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 โ€ฆ
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohnโ€™s disease,โ€ฆ
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohnโ€™s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xxโ€ฆ
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 โ€ฆ
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohnโ€™s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohnโ€™s disease and ulcerative colitis in the US was 201 and 238 perโ€ฆ
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For โ€ฆ
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex andโ€ฆ